Citadel Advisors - ELEDON PHARMACEUTICALS INC ownership

ELEDON PHARMACEUTICALS INC's ticker is ELDN and the CUSIP is 28617K101. A total of 34 filers reported holding ELEDON PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of ELEDON PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$16,906
-81.2%
12,340
-67.6%
0.00%
Q1 2023$89,940
+83.6%
38,110
+90.6%
0.00%
Q2 2022$49,000
-29.0%
20,000
+14.3%
0.00%
Q1 2022$69,000
+53.3%
17,500
+72.0%
0.00%
Q4 2021$45,000
-43.8%
10,174
-21.1%
0.00%
Q3 2021$80,000
-70.1%
12,900
-48.5%
0.00%
Q1 2021$268,00025,0620.00%
Other shareholders
ELEDON PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Logos Global Management LP 1,339,793$10,598,0000.89%
CM Management, LLC 75,000$593,0000.43%
Cormorant Asset Management, LP 1,415,500$11,197,0000.38%
BVF INC/IL 1,113,435$8,807,0000.33%
Ikarian Capital, LLC 350,000$2,769,0000.22%
Woodline Partners LP 857,445$6,782,0000.13%
INGALLS & SNYDER LLC 51,149$405,0000.02%
ADAGE CAPITAL PARTNERS GP, L.L.C. 853,208$6,749,0000.01%
BOOTHBAY FUND MANAGEMENT, LLC 40,052$317,0000.01%
Point72 Asset Management, L.P. 188,690$1,493,0000.01%
View complete list of ELEDON PHARMACEUTICALS INC shareholders